Skip to main content

Table 2 Patients’ outcomes and survival

From: Effects of endotoxin adsorber hemoperfusion on sublingual microcirculation in patients with septic shock: a randomized controlled trial

Group

Control

PMX-HP

p values

Number of patients

14

14

 

Renal replacement therapy, n (%)

2 (14%)

3 (21%)

1.000

Ventilator use (days)

5 (3–8)

5 (3–13)

0.571

Intensive care unit stay (days)

7 (5–12)

9 (5–20)

0.685

Hospital stay (days)

22 (15–50)

29 (19–51)

0.479

28-day survival, n (%)

13 (93%)

13 (93%)

1.000

  1. Data are presented as the number (%) or median (interquartile range)
  2. PMX-HP polymyxin B hemoperfusion